Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma

NCT03097939 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Ipilimumab
DRUG: Nivolumab

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]
[object Object]